SYNDAX PHARMACEUTICALS INC shareholders Q3 2023

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

SYNDAX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 10,900$158,2680.09%
Point72 Asset Management, L.P. 2,094,201$30,407,7990.09%
SILVERARC CAPITAL MANAGEMENT, LLC 20,000$290,4000.09%
Jump Financial, LLC 154,786$2,247,4930.09%
BOOTHBAY FUND MANAGEMENT, LLC 226,600$3,290,2320.08%
XTX Topco Ltd 29,864$433,6250.07%
FOX RUN MANAGEMENT, L.L.C. 15,320$222,4460.07%
MOORE CAPITAL MANAGEMENT, LP 200,000$2,904,0000.05%
Inspire Advisors, LLC 20,561$298,5460.05%
TWINBEECH CAPITAL LP 188,110$2,731,3570.05%
Virtus ETF Advisers LLC 4,532$65,8050.04%
PROFUND ADVISORS LLC 48,042$697,5700.04%
Inspire Investing, LLC 21,095$306,2990.04%
Engineers Gate Manager LP 70,536$1,024,1830.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,520,0000.03%
Y-Intercept (Hong Kong) Ltd 22,043$320,0640.03%
JENNISON ASSOCIATES LLC 2,347,673$34,088,2110.03%
BOOTHBAY FUND MANAGEMENT, LLC 85,300$1,238,5560.03%
BOOTHBAY FUND MANAGEMENT, LLC 76,909$1,116,7190.03%
Schonfeld Strategic Advisors LLC 218,413$3,171,3560.02%
External links

This page lists SYNDAX PHARMACEUTICALS INC's shareholders in Q3 2023. To view SYNDAX PHARMACEUTICALS INC's shareholder history, click here.